Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

Forgot your password?

Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

I agree to TheMaven'sTerms andPolicy

Already have an account? Login here

JIM CRAMER INVESTING PERSONAL FINANCE RETIREMENT TECHNOLOGY MARKETS HOW-TO VIDEO FINANCIAL ADVISOR CENTER

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

Axcella Announces Upcoming Presentation At J.P. Morgan Healthcare Conference

By Business Wire
Jan 5, 2021 7:58 AM EST

Axcella Announces Upcoming Investor Conference Presentation

By Business Wire
Nov 20, 2020 7:30 AM EST

Axcella To Report Third Quarter 2020 Financial Results And Hold Conference Call On November 12, 2020

By Business Wire
Oct 29, 2020 8:00 AM EDT

Axcella Announces Upcoming Presentations At AASLD's The Liver Meeting® 2020

By Business Wire
Oct 2, 2020 7:58 AM EDT

New Publication Highlights Therapeutic Potential Of Endogenous Metabolic Modulators (EMMs)

By Business Wire
Sep 30, 2020 7:28 AM EDT

Axcella Announces Upcoming Investor Conference Presentation

By Business Wire
Sep 29, 2020 7:58 AM EDT

Axcella's Late-Breaker Data From AXA1125-003 Clinical Study Presented At The EASL Digital International Liver Congress

By Business Wire
Aug 27, 2020 8:00 AM EDT

Axcella Announces Upcoming Later-Breaker Presentation At The Digital International Liver Congress 2020

By Business Wire
Aug 20, 2020 7:30 AM EDT

Results Of Axcella's AXA1665-001 Clinical Study Published In Clinical And Translational Gastroenterology

By Business Wire
Aug 17, 2020 7:30 AM EDT

Axcella To Report Second Quarter 2020 Financial Results And Hold Conference Call On August 5, 2020

By Business Wire
Aug 3, 2020 8:00 AM EDT

Flagship Pioneering's Scientists Invent A New Category Of Genome Engineering Technology: Gene Writing

By PR Newswire
Jul 7, 2020 8:00 AM EDT

Axcella Announces Patent Issuances Covering AXA1665

By Business Wire
Jun 17, 2020 8:00 AM EDT

Axcella To Present At Goldman Sachs 41st Annual Global Healthcare Conference

By Business Wire
Jun 3, 2020 8:00 AM EDT

Axcella Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Underwriters' Option

By Business Wire
May 18, 2020 4:05 PM EDT

Axcella Announces Pricing Of Public Offering Of Common Stock

By Business Wire
May 13, 2020 10:31 PM EDT

Axcella To Report Top-Line Data From AXA1125-003 In Adult Subjects With NAFLD On May 6, 2020

By Business Wire
May 5, 2020 4:05 PM EDT

Axcella To Hold Virtual-Only 2020 Annual Meeting Of Stockholders

By Business Wire
May 4, 2020 4:05 PM EDT

Axcella Receives Fourth Patent Covering EMM Compositions

By Business Wire
Apr 7, 2020 8:00 AM EDT

Axcella Completes Enrollment Of Subjects In AXA1665-002 Study

By Business Wire
Feb 26, 2020 7:30 AM EST

Axcella To Present At The SVB Leerink 9th Annual Global Healthcare Conference

By Business Wire
Feb 19, 2020 8:00 AM EST

Axcella To Present At J.P. Morgan Healthcare Conference

By Business Wire
Jan 9, 2020 8:00 AM EST

Axcella Announces Positive Interim Findings From Ongoing Clinical Study Of AXA1125/AXA1957 In Subjects With NAFLD And Expected 2020 Milestones

By Business Wire
Jan 8, 2020 8:00 AM EST

Terms Of Use
Privacy Policy
Advertise
Reprints
Customer Service
Data
Topic Archive
Subscriptions

© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.